These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Pregnancy complications in women with polycystic ovary syndrome. Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684 [TBL] [Abstract][Full Text] [Related]
64. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768 [TBL] [Abstract][Full Text] [Related]
65. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Ganie MA; Vasudevan V; Wani IA; Baba MS; Arif T; Rashid A Indian J Med Res; 2019 Oct; 150(4):333-344. PubMed ID: 31823915 [TBL] [Abstract][Full Text] [Related]
66. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310 [TBL] [Abstract][Full Text] [Related]
67. A genetic risk score is associated with polycystic ovary syndrome-related traits. Lee H; Oh JY; Sung YA; Chung HW Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528 [TBL] [Abstract][Full Text] [Related]
68. Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity. Chiu WL; Boyle J; Vincent A; Teede H; Moran LJ Neuroendocrinology; 2017; 104(4):412-424. PubMed ID: 28006770 [TBL] [Abstract][Full Text] [Related]
70. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome. Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895 [TBL] [Abstract][Full Text] [Related]
71. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728 [TBL] [Abstract][Full Text] [Related]
72. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Maleki V; Izadi A; Farsad-Naeimi A; Alizadeh M Nutr Res; 2018 Aug; 56():1-10. PubMed ID: 30055769 [TBL] [Abstract][Full Text] [Related]
73. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. Cui P; Ma T; Tamadon A; Han S; Li B; Chen Z; An X; Shao LR; Wang Y; Feng Y Exp Physiol; 2018 Dec; 103(12):1618-1632. PubMed ID: 30204276 [TBL] [Abstract][Full Text] [Related]
75. Insulin-lowering agents in the management of polycystic ovary syndrome. De Leo V; la Marca A; Petraglia F Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747 [TBL] [Abstract][Full Text] [Related]
76. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome. Di Bari F; Catalano A; Bellone F; Martino G; Benvenga S Metabolites; 2021 Feb; 11(2):. PubMed ID: 33670644 [TBL] [Abstract][Full Text] [Related]